• Sermorelin vs Ipamorelin: Comparing Two GH-Releasing Research Peptides

    Sermorelin vs Ipamorelin: Comparing Two GH-Releasing Research Peptides

    If you’ve ever looked into growth hormone-releasing peptides, you’ve probably heard of two names: sermorelin and ipamorelin. These two names are often mentioned together; sometimes they’re even written with a comma or a slash between them, and I think they’re practically the same thing. However, there is a difference between them, and it’s much greater…


  • Tirzepatide vs. Semaglutide: What the Dual vs. Single Agonist Research Shows

    Tirzepatide vs. Semaglutide: What the Dual vs. Single Agonist Research Shows

    Tirzepatide and semaglutide are arguably the most talked-about weight-loss peptides today. There is a perfectly logical explanation for this: both peptides have been approved by the FDA as prescription medications and are being actively studied in large-scale clinical programs. But what is the difference? Why has the comparison between tirzepatide and semaglutide become central to…


  • KLOW Blend: The Research Case for Combining BPC-157, TB-500, KPV and GHK-Cu

    KLOW Blend: The Research Case for Combining BPC-157, TB-500, KPV and GHK-Cu

    Executive Summary: Key Takeaways For researchers scanning for immediate protocol relevance, here are the core technical data points on the KLOW blend: Comprehensive Cascade Coverage: KLOW combines four peptides targeting the full inflammation-healing cascade: KPV (immune modulation), BPC-157 (angiogenesis and gut repair), TB-500 (cellular migration), and GHK-Cu (matrix remodeling and antioxidant defense). No Blend-Level Data…